Kaira Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 42.17%
- Profit Growth 372.64%
- Ebitda -71.26%
- Net Worth 43.93%
- Total Assets 35.88%
About Kaira Life Sciences
Kaira Life Sciences Private Limited (KLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 June 2017 (Seven years and seven months 18 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Syeda Humera and Saiyad Uzair serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52609DL2017PTC319073
- Company No.
319073
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Kaira Life Sciences Private Limited offer?
Kaira Life Sciences Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Brain & Nervous System Drugs, Immunomodulator Drugs, Anti Cancer Injection, Anti Infective Drugs & Medicines, Antiviral Drugs, Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Kaira Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syeda Humera  | Director | 12-Jun-2017 | Current |
| Saiyad Uzair | Director | 12-Jun-2017 | Current |
Financial Performance of Kaira Life Sciences.
Kaira Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.17% increase. The company also saw a substantial improvement in profitability, with a 372.64% increase in profit. The company's net worth Soared by an impressive increase of 43.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaira Life Sciences?
Unlock access to Kaira Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Winx Medihaat Innovations Private LimitedSyeda Humera is a mutual person
- Amd Global Net Private Limited
Syeda Humera is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kaira Life Sciences?
Unlock and access historical data on people associated with Kaira Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaira Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaira Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.